[Comparative characteristics of the efficacy and safety of the original alteplase and its complete biosimilar in the treatment of ischemic stroke in real clinical practice].

Objective: To conduct a comparative analysis between the original alteplase and its biosimilar in terms of efficacy and safety in real clinical practice in the Republic of Belarus.

Material And Methods: The cohort study included 420 patients. All included patients underwent thrombolytic therapy with alteplase within 4.